A citation-based method for searching scientific literature

Akira Shimada, Toshiaki Hanafusa, Atsutaka Yasui, Ganghyuck Lee, Yusuke Taneda, Akiko Sarashina, Kosuke Shiki, Jyothis George, Nima Soleymanlou, Jan Marquard. Diabetes Obes Metab 2018
Times Cited: 15







List of co-cited articles
95 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Effects of acarbose treatment in Type 2 diabetic patients under dietary training: a multicentre, double-blind, placebo-controlled, 2-year study.
H Hasche, G Mertes, C Bruns, R Englert, P Genthner, D Heim, P Heyen, G Mahla, C Schmidt, B Schulze-Schleppinghof,[...]. Diabetes Nutr Metab 1999
22
6


Randomized efficacy and safety trial of once-daily remogliflozin etabonate for the treatment of type 2 diabetes.
A P Sykes, G L Kemp, R Dobbins, R O'Connor-Semmes, S R Almond, W O Wilkison, S Walker, L Kler. Diabetes Obes Metab 2015
15
6


Addition of exenatide BID to insulin glargine: a post-hoc analysis of the effect on glycemia and weight across a range of insulin titration.
John B Buse, Jenny Han, Stephan Miller, Leigh MacConell, Richard Pencek, Matthew Wintle. Curr Med Res Opin 2014
4
25


Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience.
David A Henry, Ian H Kerridge, Suzanne R Hill, Paul M McNeill, Evan Doran, David A Newby, Kim M Henderson, Jane Maguire, Barrie J Stokes, Graham J Macdonald,[...]. Med J Aust 2005
27
6


Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control.
Jan Šoupal, Jan Škrha, Martin Fajmon, Eva Horová, Miloš Mráz, Jan Škrha, Martin Prázný. Diabetes Technol Ther 2014
51
6

NICE guidance on sotagliflozin for type 1 diabetes.
Amanda I Adler, Jessica Cronshaw, Carl Prescott, Sanjeev Patel, Eleanor Donegan, Jasdeep Hayre. Lancet Diabetes Endocrinol 2020
3
33


How should meta-regression analyses be undertaken and interpreted?
Simon G Thompson, Julian P T Higgins. Stat Med 2002
6

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer,[...]. J Clin Epidemiol 2011
6

Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews.
Rebecca M Turner, Jonathan Davey, Mike J Clarke, Simon G Thompson, Julian Pt Higgins. Int J Epidemiol 2012
343
6

Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis.
Esther Donga, Olaf M Dekkers, Eleonora P M Corssmit, Johannes A Romijn. Eur J Endocrinol 2015
33
6

Controlling the risk of spurious findings from meta-regression.
Julian P T Higgins, Simon G Thompson. Stat Med 2004
651
6

Sponsorship bias in clinical research.
Joel Lexchin. Int J Risk Saf Med 2012
23
6

Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function.
Brendon L Neuen, Toshiaki Ohkuma, Bruce Neal, David R Matthews, Dick de Zeeuw, Kenneth W Mahaffey, Greg Fulcher, Mehul Desai, Qiang Li, Hsiaowei Deng,[...]. Circulation 2018
105
6


Recommendations for assessing the risk of bias in systematic reviews of health-care interventions.
Meera Viswanathan, Carrie D Patnode, Nancy D Berkman, Eric B Bass, Stephanie Chang, Lisa Hartling, M Hassan Murad, Jonathan R Treadwell, Robert L Kane. J Clin Epidemiol 2018
36
6

SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme Caution.
Joseph I Wolfsdorf, Robert E Ratner. Diabetes Care 2019
8
12

Diabetic ketoacidosis with SGLT2 inhibitors.
Giovanni Musso, Francesca Saba, Maurizio Cassader, Roberto Gambino. BMJ 2020
4
25

Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study.
Christopher C Patterson, Valma Harjutsalo, Joachim Rosenbauer, Andreas Neu, Ondrej Cinek, Torild Skrivarhaug, Birgit Rami-Merhar, Gyula Soltesz, Jannet Svensson, Roger C Parslow,[...]. Diabetologia 2019
87
6

Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force.
George Grunberger, Jill M Abelseth, Timothy S Bailey, Bruce W Bode, Yehuda Handelsman, Richard Hellman, Lois Jovanovič, Wendy S Lane, Philip Raskin, William V Tamborlane,[...]. Endocr Pract 2014
76
6

The number of subjects per variable required in linear regression analyses.
Peter C Austin, Ewout W Steyerberg. J Clin Epidemiol 2015
301
6

Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.
Michael J Bradburn, Jonathan J Deeks, Jesse A Berlin, A Russell Localio. Stat Med 2007
512
6

Constraints on publication rights in industry-initiated clinical trials.
Peter C Gøtzsche, Asbjørn Hróbjartsson, Helle Krogh Johansen, Mette T Haahr, Douglas G Altman, An-Wen Chan. JAMA 2006
47
6


The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
6

Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats.
Rachel J Perry, Aviva Rabin-Court, Joongyu D Song, Rebecca L Cardone, Yongliang Wang, Richard G Kibbey, Gerald I Shulman. Nat Commun 2019
29
6

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.
C P Wilkinson, Frederick L Ferris, Ronald E Klein, Paul P Lee, Carl David Agardh, Matthew Davis, Diana Dills, Anselm Kampik, R Pararajasegaram, Juan T Verdaguer. Ophthalmology 2003
6

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
Yehuda Handelsman, Robert R Henry, Zachary T Bloomgarden, Sam Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian A Fonseca, Alan J Garber, George Grunberger,[...]. Endocr Pract 2016
146
6

NICE guidance on dapagliflozin with insulin for type 1 diabetes.
Amanda I Adler, Sharlene Ting, Ross Dent, Nick Latimer. Lancet Diabetes Endocrinol 2019
6
16

Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?
David J Fisher, James R Carpenter, Tim P Morris, Suzanne C Freeman, Jayne F Tierney. BMJ 2017
55
6






Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.